SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: Are they effective and why? A systematic review. Biol. Psychiatry 2006; 59: 10291038.
  • 2
    Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: Treating depression in the real world. Cleve. Clin. J. Med. 2008; 75: 5766.
  • 3
    Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: A meta-analysis comparing within- versus across-class switches. Biol. Psychiatry 2008; 63: 699704.
  • 4
    Quitkin FM, McGrath PJ, Stewart JW et al. Remission rates with 3 consecutive antidepressant trials: Effectiveness for depressed outpatients. J. Clin. Psychiatry 2005; 66: 670676.
  • 5
    Crismon ML, Trivedi M, Pigott TA et al. The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder. J. Clin. Psychiatry 1999; 60: 142156.
  • 6
    Adli M, Berghofer A, Linden M et al. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: Results of a 2-year observational algorithm study. J. Clin. Psychiatry 2002; 63: 782790.
  • 7
    Bondolfi G, Aubry JM, Golaz J, Gex-Fabry M, Gervasoni N, Bertschy G. A stepwise drug treatment algorithm to obtain complete remission in depression: A Geneva study. Swiss Med. Wkly. 2006; 136: 7885.
  • 8
    Trivedi MH, Rush AJ, Crismon ML et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch. Gen. Psychiatry 2004; 61: 669680.
  • 9
    Motohashi N. Algorithm for the Treatment of Mood Disorder (in Japanese). Jiho, Tokyo, 2003.
  • 10
    Nomura S, Sawamura T, Kobayashi N, Yoshino A. Medication algorithm for mood disorders: Present status and future direction in Japan. Int. J. Psychiatry Clin. 2004; 8: 139145.
  • 11
    Valenstein M, McCarthy JF, Austin KL, Greden JF, Young EA, Blow FC. What happened to lithium? Antidepressant augmentation in clinical settings. Am. J. Psychiatry 2006; 163: 12191225.
  • 12
    Nierenberg AA, Amsterdam JD. Treatment-resistant depression: Definition and treatment approaches. J. Clin. Psychiatry 1990; 51 (Suppl.): 3947.
  • 13
    Dording CM. Antidepressant augmentation and combinations. Psychiatr. Clin. North Am. 2000; 23: 743755.
  • 14
    Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: Two meta-analyses of randomized, placebo-controlled trials. J. Clin. Psychiatry 2007; 68: 935940.
  • 15
    Guy W. Early Clinical Drug Evaluation (ECDEU) Assessment Manual. National Institute for Mental Health, Rockville, MD, 1976.
  • 16
    Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr. Pharm. Des. 2006; 12: 29852992.